Author(s): Jung YH, Heo J, Lee YJ, Kwon TK, Kim YH
Aims: Quercetin has been shown to enhance tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of prostate cancer cells via mechanisms that include upregulation of death receptor (DR) 5, a protein reported to play an important role in sensitizing cancer cells to apoptosis. We aimed to determine the specific mechanisms underlying quercetin-induced DR5 expression.
Main methods: Human prostate cancer cells were exposed to quercetin and TRAIL. Trypan blue assays and terminal transferase dUTP nick-end labeling (TUNEL) assays evaluated changes in TRAIL resistance after quercetin treatment, and flow cytometry examined quercetin-induced death receptor expression in DU-145 cells. Western blotting, reverse transcription-polymerase chain reaction (RT-PCR) and transiently transfection were utilized to confirm apoptotic patterns of prostate cancer cells.
Key findings: After stimulation with quercetin, DU-145 cells exhibited stronger sensitization to TRAIL. Quercetin treatment enhanced TRAIL-induced activation proteins in the caspase pathway, such as poly (ADP-ribose) polymerase (PARP), caspase-3, and caspase-9. Quercetin dose-dependently increased DR5 levels in prostate cancer cells, which was mediated by increased transcription and protein stability, but not mRNA stability. Ectopic expression of DR5 dose-dependently increased TRAIL-induced apoptosis.
Significance: Our results showed that the role of quercetin and TRAIL combination therapy may provide a novel strategy for treating prostate cancer by overcoming critical mechanisms of apoptosis resistance.
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/20096292
Author(s): Ting AT, Pimentel-Muinos FX, Seed B
Author(s): Reynaert NL, Ckless K, Korn SH, Vos N, Guala AS, et al.
Author(s): Pandey MK, Sung B, Ahn KS, Kunnumakkara AB, Chaturvedi MM, et al.
Author(s): Ha KH, Byun MS, Choi J, Jeong J, Lee KJ, et al.
Author(s): Vanhaesebroeck B, Waterfield MD
Author(s): Vivanco I, Sawyers CL
Author(s): Kandel ES, Skeen J, Majewski N, Di Cristofano A, Pandolfi PP, et al.
Author(s): Kandel ES, Hay N
Author(s): Choi JA, Kim JY, Lee JY, Kang CM, Kwon HJ, et al.
Author(s): Kuo PC, Liu HF, Chao JI
Author(s): Ong CS, Tran E, Nguyen TT, Ong CK, Lee SK, et al.
Author(s): Vijayababu MR, Arunkumar A, Kanagaraj P, Arunakaran J
Author(s): Choi EJ, Bae SM, Ahn WS
Author(s): Senthilkumar K, Elumalai P, Arunkumar R, Banudevi S, Gunadharini ND, et al.
Author(s): Senthilkumar K, Arunkumar R, Elumalai P, Sharmila G, Gunadharini DN, et al.
Author(s): Yi L, Su Q
Author(s): Gupta SC, Reuter S, Phromnoi K, Park B, Hema PS, et al.
Author(s): Babykutty S, S PP, J NR, Kumar MA, Nair MS, et al.
Author(s): Kavitha K, Vidya Priyadarsini R, Anitha P, Ramalingam K, Sakthivel R, et al.
Author(s): Lowry OH, Rosebrough NJ, Farr AL, Randall RJ
Author(s): Arunkumar A, Vijayababu MR, Srinivasan N, Aruldhas MM, Arunakaran J
Author(s): Gayathri R, Gunadharini DN, Arunkumar A, Senthilkumar K, Krishnamoorthy G, et al.